Glioblastoma, Amyvid
Showing 1 - 25 of 1,155
Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)
Not yet recruiting
- Glioblastoma
- Amyvid, Intravenous Solution
-
Bayamon, Puerto Rico
- +1 more
Apr 18, 2023
Glioblastoma, IDH-wildtype Trial in Rome (Biological biomarker analysis)
Not yet recruiting
- Glioblastoma, IDH-wildtype
- Biological biomarker analysis
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Jul 3, 2023
Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma Trial in Los Angeles (Biospecimen Collection, Magnetic Resonance
Recruiting
- Glioblastoma
- +2 more
- Biospecimen Collection
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
History of Tonsillectomy or Adenoidectomy on Severity of
Not yet recruiting
- Tonsillectomy
- +2 more
- health questionnaire
- (no location specified)
Jul 6, 2023
Glioblastoma Trial in Berlin (Radiofrequency electromagnetic field treatment)
Recruiting
- Glioblastoma
- Radiofrequency electromagnetic field treatment
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Nov 15, 2023
Glioblastoma Trial in Aarhus (Escalated proton therapy)
Not yet recruiting
- Glioblastoma
- Escalated proton therapy
-
Aarhus, DenmarkDanish Center for Particle Therapy
Mar 2, 2023
Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))
Active, not recruiting
- Glioblastoma
- Ibrutinib
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Glioblastoma Multiforme Trial in Shijia Zhuang (TMZ)
Recruiting
- Glioblastoma Multiforme
-
Shijia Zhuang, Hebei, Chinathe Second Hospital of HeBei Medical University
Oct 18, 2022
MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)
Not yet recruiting
- MGMT-Unmethylated Glioblastoma
- Etoposide Plus Cisplatin
- (no location specified)
Jan 12, 2023
Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)
Recruiting
- Recurrent Glioblastoma
- Refractory Glioblastoma
- Temozolomide
- B7-H3 CAR-T
-
Hangzhou, Zhejiang, China
- +2 more
Dec 25, 2022
Glioblastoma Through Preservation of Biologically Active Brain
Not yet recruiting
- Glioblastoma
- +2 more
- Specimen Collection
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 24, 2023
Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)
Not yet recruiting
- Glioblastoma
- 18F-GE-180 PET
- +4 more
-
Rozzano, (mi), ItalyIRCCS Istituto Clinico Humanitas
Oct 27, 2023
Glioblastoma Trial (Psychosocial Support Intervention)
Not yet recruiting
- Glioblastoma
- Psychosocial Support Intervention
- (no location specified)
Sep 8, 2023
Glioblastoma Trial (PET imaging)
Not yet recruiting
- Glioblastoma
- PET imaging
- (no location specified)
Feb 23, 2023
Glioblastoma Multiforme Trial in United States (Keto Diet, Usual Diet)
Not yet recruiting
- Glioblastoma Multiforme
- Keto Diet
- Usual Diet
-
Los Angeles, California
- +4 more
Jan 31, 2023
A Close Examination of Patient Experiences in Glioblastoma
Not yet recruiting
- Glioblastoma Multiforme
-
San Francisco, CaliforniaPower Life Sciences
Jul 14, 2023
Glioblastoma Trial (plasma collection)
Not yet recruiting
- Glioblastoma
- plasma collection
- (no location specified)
Aug 18, 2023
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor
Recruiting
- Glioblastoma
- Lumber Puncture
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All protocol activites)
Jun 28, 2023